Literature DB >> 7527376

A secreted mucin carrying sialyl-Lewis a from colon carcinoma cells binds to E-selectin and inhibits HL-60 cell adhesion.

K Zhang1, D Baeckström, G C Hansson.   

Abstract

Sialyl-Lewis x and a are known as ligands for E-selectin (ELAM-I) involved in leukocyte-endothelial adhesion. L-CanAg (light cancer antigen), secreted by a colon carcinoma cell line COLO 205, is a soluble mucin-type glycoprotein expressing sialyl-Lewis a antigens. L-CanAg was purified from spent culture medium by trichloracetic acid precipitation and Superose 6 gel filtration. With a monoclonal antibody against E-selectin (BBAI) as a positive control, the purified L-CanAg was shown to bind to E-selectin-Fc coated into plastic microtiter wells and to the surface of transiently E-selectin-transfected COS-I cells in a Ca(2+)-dependent way. Immunofluorescent double labelling showed that both BBAI and L-CanAg stained the same cells and morphological co-localization on E-selectin-transfected COS-I cells. Like BBAI, L-CanAg can inhibit leukocyte HL-60 cell adhesion to E-selectin-transfected COS-I cells, and this inhibition can be blocked by a F(ab')2 fragment directed against the sialyl-Lewis a epitope.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7527376     DOI: 10.1002/ijc.2910590619

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  7 in total

1.  Distinct selectin ligands on colon carcinoma mucins can mediate pathological interactions among platelets, leukocytes, and endothelium.

Authors:  Y J Kim; L Borsig; H L Han; N M Varki; A Varki
Journal:  Am J Pathol       Date:  1999-08       Impact factor: 4.307

2.  Immunohistochemical expression of the sialyl Lewis x antigen on gastric cancer cells correlates with the presence of liver metastasis.

Authors:  M Tatsumi; A Watanabe; H Sawada; Y Yamada; Y Shino; H Nakano
Journal:  Clin Exp Metastasis       Date:  1998-11       Impact factor: 5.150

3.  Tumor cell MUC1 and CD43 are glycosylated differently with sialyl-Lewis a and x epitopes and show variable interactions with E-selectin under physiological flow conditions.

Authors:  J Fernandez-Rodriguez; O Dwir; R Alon; G C Hansson
Journal:  Glycoconj J       Date:  2001 Nov-Dec       Impact factor: 2.916

4.  Triphasic force dependence of E-selectin/ligand dissociation governs cell rolling under flow.

Authors:  Annica M Wayman; Wei Chen; Rodger P McEver; Cheng Zhu
Journal:  Biophys J       Date:  2010-08-09       Impact factor: 4.033

Review 5.  Perspectives on the significance of altered glycosylation of glycoproteins in cancer.

Authors:  Y J Kim; A Varki
Journal:  Glycoconj J       Date:  1997-08       Impact factor: 2.916

6.  Increased E-selectin in hepatic ischemia-reperfusion injury mediates liver metastasis of pancreatic cancer.

Authors:  Katsuhiro Yoshimoto; Hidehiro Tajima; Tetsuo Ohta; Koichi Okamoto; Seisho Sakai; Jun Kinoshita; Hiroyuki Furukawa; Isamu Makino; Hironori Hayashi; Keishi Nakamura; Katsunobu Oyama; Masafumi Inokuchi; Hisatoshi Nakagawara; Hiroshi Itoh; Hideto Fujita; Hiroyuki Takamura; Itasu Ninomiya; Hirohisa Kitagawa; Sachio Fushida; Takashi Fujimura; Tomohiko Wakayama; Shoichi Iseki; Koichi Shimizu
Journal:  Oncol Rep       Date:  2012-07-03       Impact factor: 3.906

Review 7.  Glyco-engineering for biopharmaceutical production in moss bioreactors.

Authors:  Eva L Decker; Juliana Parsons; Ralf Reski
Journal:  Front Plant Sci       Date:  2014-07-09       Impact factor: 5.753

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.